Latest Listings And Ipos News

MLG Oz Limited has locked in contracts worth over $45 million annually with Northern Star Resources, extending a partnership spanning more than 10 years across key Western Australian gold operations.

Green Critical Minerals Limited (ASX: GCM) has temporarily paused trading of its securities, signaling an impending announcement that investors should watch closely.

OD6 Metals has completed the acquisition of the historic Gulf Creek Copper Project in New South Wales, positioning itself to unlock significant copper potential using modern exploration techniques.

Fonterra Shareholders' Fund has secured conditional approval to delist from the ASX, aiming to consolidate its trading on the NZX by late February 2025. This move is expected to streamline operations and reduce costs for unitholders.

Resources & Energy Group Ltd (REZ) has clarified recent trading activity in its shares, attributing the surge to a significant rise in gold prices rather than undisclosed information. The company remains focused on its Maranoa gold recovery program, with further results pending.

Yancoal Australia announces the resignation of CEO David Moult after five years in the role, with Ning Yue appointed as acting CEO during the search for a permanent successor.

Cardno Limited has requested an immediate suspension from ASX quotation to facilitate its removal from the official ASX list, marking a significant step in its delisting process.

First Graphene Limited has responded to an ASX price query, attributing its recent share price and volume surge to increased buying activity in Germany linked to prior commercial announcements, while reaffirming full compliance with ASX disclosure rules.

Nex Metals Explorations has repriced and partially completed its capital raise, securing $1.06 million at a reduced share price to fund development and exploration activities.

The Supreme Court of New South Wales has approved the scheme of arrangement for Southern Cross Gold Consolidated Ltd to acquire all remaining shares of Southern Cross Gold Ltd, setting the stage for a significant ownership consolidation and ASX trading changes.

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

Latrobe Magnesium Limited has responded to an ASX price query, denying any undisclosed information that could explain the recent sharp drop in its share price and surge in trading volume.